Psychopharmacology: Psychopharmacology (From Greek Psȳkhē, "Breath, Life, Soul" Pharmakon, "Drug") Is The Study of Drug
Psychopharmacology: Psychopharmacology (From Greek Psȳkhē, "Breath, Life, Soul" Pharmakon, "Drug") Is The Study of Drug
Psychopharmacology: Psychopharmacology (From Greek Psȳkhē, "Breath, Life, Soul" Pharmakon, "Drug") Is The Study of Drug
Psychopharmacology (from Greek psȳkhē, "breath, life, soul" pharmakon, "drug") is the study of drug-
induced changes in mood, sensation, thinking, and behavior.
The field of psychopharmacology studies a wide range of substances with various types of psychoactive
properties. The professional and commercial fields of pharmacology and psychopharmacology do not
mainly focus on psychedelic or recreational drugs, as the majority of studies are conducted for the
development, study, and use of drugs for the modification of behavior and the alleviation of symptoms,
particularly in the treatment of mental disorders (psychiatric medication). While studies are conducted on
all psychoactives by both fields, psychopharmacology focuses primarily on the psychoactive and chemical
interactions with the brain.
Drugs are researched for their physicochemical properties, physical side effects, and psychological side
effects. Researchers in psychopharmacology study a variety of different psychoactive substances that
include alcohol, cannabinoids, club drugs, psychedelics, opiates, nicotine, caffeine, psychomotor
stimulants, inhalants, and anabolic-androgenic steroids. They also study drugs used in the treatment of
affective and anxiety disorders, as well as schizophrenia.
Clinical studies are often very specific, typically beginning with animal testing, and ending with human
testing. In the human testing phase, there is often a group of subjects, one group is given a placebo, and
the other is administered a carefully measured therapeutic dose of the drug in question. After all of the
testing is completed, the drug is proposed to the concerned regulatory authority (e.g. the U.S. FDA), and
is either commercially introduced to the public via prescription, or deemed safe enough for over the
counter sale.
Though particular drugs are prescribed for specific symptoms or syndromes, they are usually not specific
to the treatment of any single mental disorder. Because of their ability to modify the behavior of even
the most disturbed patients, the antipsychotic, antianxiety, and antidepressant agents have greatly
affected the management of the hospitalized mentally ill, enabling hospital staff to devote more of their
attention to therapeutic efforts and enabling many patients to lead relatively normal lives outside of the
hospital. A somewhat controversial application of psychopharmacology is "cosmetic psychiatry" Persons
who do not meet criteria for any psychiatric disorder are nevertheless prescribed psychotropic
medication. The antidepressant Wellbutrin is then prescribed to increase perceived energy levels and
assertiveness while diminishing the need for sleep. The antihypertensive compound Inderal is
sometimes chosen to eliminate the discomfort of day-to-day "normal" anxiety . Prozac in nondepressed
people can produce a feeling of generalized well-being. Mirapex, a treatment for restless leg syndrome,
can dramatically increase libido in women. These and other off-label life-style applications of
medications are not uncommon. Although occasionally reported in the medical literature no guidelines
for such usage have been developed.
Undifferentiated Schizophrenia
The undifferentiated subtype is diagnosed when people have symptoms of schizophrenia that are
not sufficiently formed or specific enough to permit classification of the illness into one of the
other subtypes.
The symptoms of any one person can fluctuate at different points in time, resulting in uncertainty
as to the correct subtype classification. Other people will exhibit symptoms that are remarkably
stable over time but still may not fit one of the typical subtype pictures. In either instance,
diagnosis of the undifferentiated subtype may best describe the mixed clinical syndrome.
How Is It Diagnosed?
Hallucinations
"A false perception, which is not a sensory distortion or misinterpretations but which occurs as
the same time as real perceptions" - (Jaspers)
Dreams and mental images differ from hallucinations and are often Incomplete,
dependent on will, can be recreated.
Pseudo-hallucinations.
Causes of hallucinations
Intense emotions.
Depression
Words or short phrases-”kill yourself”
Suggestions
Hypnosis
Motivating instructions
Disorders of sense organs.
Glaucoma
Geriatric clients
Sensory deprivations.
Repetitive words and phrases.
Black patch disease.
Disorders of CNS.
Lesions on diencephalon and cortex
Usually visual.
Hypnogogic and Hypnopompic
Organic hallucinations
Auditory or visual .
Auditory hallucinations
Visual hallucinations
Olfactory hallucinations
Taste hallucinations
Tactile hallucinations
Reflex hallucinations
Extracampine hallucinations
Autoscopy or phantom mirror image
Epilepsy ,focal lesions, toxic infective stages
Parietal lobe disorders
Negative autoscopy
Internal autoscopy
Delusions
False unshakable belief which is out of keeping with the patients social and cultural
background.
Primary delusions.
Secondary delusions.
Primary delusions
A new meaning arises not in connection with other psychopathological event and is not
understandable.
Delusional mood: has knowledge of something going on around him but do not know
what it is.
Delusional perception: attribution of new meaning to a normally perceived object.
Delusional idea: delusion appears fully formed in the mind.
Secondary delusions
Treatment
Antipsychotics
o Typical
o Atypical
o Sedatives / hypnotics
Steps in Management
Facilitative communication.
Observation and listening.
Can talk about hallucination to know about the level of symptoms.
Talking about hallucination is reassuring and self validating for the patient.
If left alone, it will overwhelm coping resources.
Interactive discussions are very helpful.
Communicate right at the time of hallucination.
Modulation of sensory stimulation.
Principles
Eye contact.
Speak simply but slightly louder.
Call by name.
Use touch.
Nurses responsibility
Genetic factors contribute substantially to the likelihood of developing bipolar disorder, and
environmental factors are also implicated. Bipolar disorder is often treated with mood stabilizing
medications and, sometimes, other psychiatric drugs. Psychotherapy also has a role, often when
there has been some recovery of the subject's stability. In serious cases, in which there is a risk of
harm to oneself or others, involuntary commitment may be used. These cases generally involve
severe manic episodes with dangerous behavior or depressive episodes with suicidal ideation.
There are widespread problems with social stigma, stereotypes, and prejudice against individuals
with a diagnosis of bipolar disorder.[4] People with bipolar disorder exhibiting psychotic
symptoms can sometimes be misdiagnosed as having schizophrenia, another serious mental
illness.[5]
The current term "bipolar disorder" is of fairly recent origin and refers to the cycling between
high and low episodes (poles). A relationship between mania and melancholia had long been
observed, although the basis of the current conceptualisation can be traced back to French
psychiatrists in the 1850s. The term "manic-depressive illness" or psychosis was coined by
German psychiatrist Emil Kraepelin in the late nineteenth century, originally referring to all
kinds of mood disorder. German psychiatrist Karl Leonhard split the classification again in 1957,
employing the terms unipolar disorder (major depressive disorder) and bipolar disorder.